Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 7515767.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In this study, we examined the effect of tumor necrosis factor alpha (TNF-alpha) on pulmonary metastasis of murine melanoma B16-BL6 by focusing on the intercellular adhesion molecules involved in the metastatic process. TNF-alpha administration before B16-BL6 inoculation significantly enhanced the experimental pulmonary metastasis. The enhancement was seen when TNF-alpha was administered 4 h, but not 24 h, before B16-BL6 inoculation. Administration of 50-5000 units of TNF-alpha increased the number of metastatic lung colonies in a dose-dependent manner. Flow cytometric analysis demonstrated a high expression of very late activation antigen 4 (VLA-4) on the surface of B16-BL6 cells. Immunoperoxidase staining demonstrated that a ligand for VLA-4, vascular cell adhesion molecule 1, was expressed on lung vascular endothelium 4 h after administration of TNF-alpha. Pretreatment of B16-BL6 cells with an anti-VLA-4 monoclonal antibody abolished the TNF-alpha-enhanced pulmonary lung colonies. Administration of an anti-vascular cell adhesion molecule 1 monoclonal antibody also abolished the enhancement. These results indicate that the interaction between VLA-4 on tumor cells and vascular cell adhesion molecule 1 on activated endothelial cells is critically involved in TNF-alpha enhancement of metastasis.
Medical subject headings
- Cell Adhesion Molecules
- Lung Neoplasms
- Melanoma, Experimental
- Receptors, Very Late Antigen
- Tumor Necrosis Factor-alpha